Hemp Gazette on MMJ and EXCLUSIVE IMPORT from Canada.
Hemp Gazette on MMJ and EXCLUSIVE IMPORT from Canada.
QBL subsidiary MCL has inked a deal with Canada’s Canntab Therapeutics to bring Canntab XR tablets into Australia.
The tablets are designed to deliver cannabinoids over a number of hours and have varying levels of THC and/or CBD. The company says the tablets take the guesswork out of cannabis medicines, which will make doctors more comfortable in prescribing them.
The enthusiastic announcement from QBL regarding the joint venture agreement claims Canntab is a “game-changing” medicine.
“Everyone knows someone who could benefit from this new technology,” said Pnina Feldman, QBL Executive Chairperson.
Canntab CEO Jeff Renwick says the deal enables the company to bring a significant advancement in cannabis-based medicines to Australia. The company will also have first rights to distribute the products throughout Asia.
“We believe that the patents filed and pending protects key features of our IP, and positions Canntab to be the definitive Cannabis delivery method of choice among the established medical professions and ever- expanding number of Australians using cannabis every day for medical purposes, and an even greater number who would find benefits from its use,” states the announcement.
Each of Canntab’s five products is available in different dosage levels (2.5mg, 5mg, and 10mg) and in instant and stable extended release. The extended-release products are designed to release the active pharmaceutical ingredient at a predetermined rate in order to maintain a constant concentration over a specific period of time; which could be up to 18 hours.
Four of the products contain THC or THC and CBD, while Canntab “Yellow” tablets only contain CBD. It’s been a busy couple of weeks for Medical Cannabis Limited. Late last month we reported it had teamed up with Australia’s Algae.Tec Ltd (ASX:AEB) in a project researching cannabis-based veterinary medications.
ABOUT US
Hemp Gazette is a medicinal marijuana and industrial hemp information website. Based in Australia, we publish the latest breaking legal, medical and business news, research and industry reports from around the world.
See QBL-board for latest UPDATES !
https://www.queenslandbauxite.com/
Here you have the possibility to take advantage on facts and info from QBL.Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up. Contact information to the QBL Investor service, who can reply on your questions, serviceminded.
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...
Continue Reading
Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...
Continue Reading
The Allure of AI Agents in Finance Ah, it's a brave new world, my friend. A hundred years ago, the financial services industry relied on flesh-and-blood analysts armed with pens and filing cabinets. Today? It's all about AI agents, and Allooloo Technologies Corp. is at the heart of the action. Just recently, they rolled out specialized zones of record for AI—datasets...
Continue Reading
Smoke and Mirrors: Honeywell's Legal Trouble Okay, here's a fun way to start your day: talking lawsuits. Honeywell Aerospace Inc. (NASDAQ:HONA), a name you'd know if you're into aircraft components and avionics, is in hot water. It seems they've been less than transparent about their business prospects, prompting a class action lawsuit from open market purchasers during a...
Continue Reading
China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...
Continue Reading
Diving Into Amber International's AGM Decisions Ah, the hum of shareholder meetings—a fancy little dance of approvals and resolutions! That's exactly what went down on October 23, 2026, for Amber International Holding Limited. A fresh roster, some hefty share awards, and strategic decisions wrapped up their recent annual gathering. Shed the lawyer-speak and let's get...
Continue Reading
Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...
Continue Reading
Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...
Continue Reading
A Milestone and a Homecoming Who would've thought? Cole Haan, the American staple that seems to draw from an old-world charm and modern flair, is making waves again. They've just hit their 600th store mark—a number not to scoff at, especially when retail's felt the squeeze lately. But it’s not just about another number. It’s about a return, a resounding "we still...
Continue Reading
Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...
Continue Reading
Top 5 Most Recently Viewed Articles
Avanos Medical Welcomes Camille Chang Gilmore Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical technology industry renowned for its innovative healthcare solutions, is excited to share the news of Camille Chang Gilmore's appointment as Senior Vice President and Chief Human Resources Officer. This strategic decision underscores Avanos' commitment to...
Continue Reading
Empowering Convenience Stores to Thrive The convenience store industry is experiencing robust growth, presenting both opportunities and challenges for business owners. Amidst this evolving landscape, Square 9 Softworks steps up as a knowledgeable ally, offering powerful insights through its latest expert guide designed specifically for C-stores. This essential resource...
Continue Reading
Unveiling of CREATEA Mighty Mango Concept Beverage CREATEA is set to turn heads with the introduction of its Mighty Mango beverage at SupplySide Global 2025. This innovative drink combines a unique formula that not only promotes physical performance through creatine but also enhances mental energy with scientifically-supported ingredients. The 12 oz ready-to-drink...
Continue Reading
Performance Brokerage Services Facilitates Dealership Sale Performance Brokerage Services, a leader in dealership buy-sell activities, recently announced the successful sale of Mark Chevrolet. The transition involved Charles Cabana, the former owner, and Bill Golling, associated with the prominent Golling Automotive Group. A Legacy of Service at Mark Chevrolet Mark...
Continue Reading
Stock Slump: What Gives? Look, I’ve been in this game long enough to know when a company’s got its back against the wall. Dillard’s is feeling the heat, and today it’s clear: the department store operator isn’t exactly riding high on the hog. Their stock, Dillard's (DDS), took a nosedive of 7.18% and is sitting at $599.80. Why? Well, it boils down to mixed...
Continue Reading